Company Sangui Biotech International, Inc.
Equities
SBH
US80105B1017
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.002 EUR | -20.00% |
|
-.--% | -33.33% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Thomas Striepe
CEO | Chief Executive Officer | 62 | 06/02/05 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Thomas Striepe
CEO | Chief Executive Officer | 62 | 06/02/05 |
Hubertus Schmelz
BRD | Director/Board Member | 68 | 17/12/08 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 209,955,598 | 182,538,524 ( 86.94 %) | 53,756 ( 0.0256 %) | 86.94 % |
Company contact information
Sangui BioTech International, Inc.
Bleichenbruecke 9
20354, Hamburg
+49 40 609 3120
http://www.sanguibiotech.com![address Sangui Biotech International, Inc.(SBH)](https://cdn.zonebourse.com/static/address/120803321.png)
Sector
1st Jan change | Capi. | |
---|---|---|
-33.33% | 450K | |
+17.07% | 45.51B | |
-10.01% | 38.52B | |
+38.08% | 38.13B | |
+28.09% | 30.74B | |
-8.64% | 26.03B | |
+11.54% | 25.92B | |
+45.15% | 14.13B | |
+33.76% | 12.73B | |
-7.63% | 11.29B |
- Stock Market
- Equities
- SBH Stock
- Company Sangui Biotech International, Inc.